Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Summary: Metabolic reprogramming in both immune and cancer cells plays a crucial role in the antitumor immune response. Recent studies indicate that cancer metabolism not only sustains carcinogenesis and survival via altered signaling but also modulates immune cell function. Metabolic crosstalk with...
Saved in:
Main Author: | Jean-Ehrland Ricci |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124724015572 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deletion of AMP-activated protein kinase impairs metastasis and is rescued by ROS scavenging or ectopic CD36 expression
by: Gopalakrishnan Ramakrishnan, et al.
Published: (2025-01-01) -
SLC7A5 is required for cancer cell growth under arginine-limited conditions
by: Kyle N. Dunlap, et al.
Published: (2025-01-01) -
Metabolic reprogramming of macrophages by PKM2 promotes IL-10 production via adenosine
by: Juliana Escher Toller-Kawahisa, et al.
Published: (2025-01-01) -
Cytosolic DNA composition is determined by genomic instability mechanism and regulates dendritic cell-mediated anti-tumor immunity
by: Shayla R. Mosley, et al.
Published: (2025-02-01) -
Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
by: Joanna Bandola-Simon, et al.
Published: (2025-01-01)